TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Vaccines & Vaccination Market, Global Outlook and Forecast 2024-2030

Vaccines & Vaccination Market, Global Outlook and Forecast 2024-2030

  • Category:Life Sciences
  • Published on : 06 February 2024
  • Pages :102
  • Formats:
  • Report Code:SMR-7899798

This research report provides a comprehensive analysis of the Vaccines & Vaccination market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Vaccines & Vaccination market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Vaccines & Vaccination, challenges faced by the industry, and potential opportunities for market players.
The global Vaccines & Vaccination market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Vaccines & Vaccination market presents opportunities for various stakeholders, including Baby Vaccine, Adult Special Vaccine. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Vaccines & Vaccination market. Additionally, the growing consumer demand present avenues for market expansion.
The global Vaccines & Vaccination market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period.
Key Features:
The research report on the Vaccines & Vaccination market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Vaccines & Vaccination market.
Market Overview: The report provides a comprehensive overview of the Vaccines & Vaccination market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Subunit vaccines, Live attenuated vaccines), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Vaccines & Vaccination market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Vaccines & Vaccination market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Vaccines & Vaccination market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Vaccines & Vaccination market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Vaccines & Vaccination market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Vaccines & Vaccination market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Vaccines & Vaccination, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Vaccines & Vaccination market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Vaccines & Vaccination market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Subunit vaccines
Live attenuated vaccines
Conjugate vaccines
Inactivated vaccines
Recombinant vector vaccines
Toxoid vaccines
Synthetic vaccines
Dendritic cell vaccines
Market segment by Application
Baby Vaccine
Adult Special Vaccine
Other
Global Vaccines & Vaccination Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Abbott
AstraZeneca
Bavarian Nordic
Novartis
Bharat Biotech
Bio-Med
CSL
Emergent BioSolutions
GSK
Johnson & Johnson
Pfizer
Merck
Sanofi
Outline of Major Chapters:
Chapter 1: Introduces the definition of Vaccines & Vaccination, market overview.
Chapter 2: Global Vaccines & Vaccination market size in revenue.
Chapter 3: Detailed analysis of Vaccines & Vaccination company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Vaccines & Vaccination in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

TABLE OF CONTENTS

1 Introduction to Research & Analysis Reports
1.1 Vaccines & Vaccination Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Vaccines & Vaccination Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Vaccines & Vaccination Overall Market Size
2.1 Global Vaccines & Vaccination Market Size: 2023 VS 2030
2.2 Global Vaccines & Vaccination Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Vaccines & Vaccination Players in Global Market
3.2 Top Global Vaccines & Vaccination Companies Ranked by Revenue
3.3 Global Vaccines & Vaccination Revenue by Companies
3.4 Top 3 and Top 5 Vaccines & Vaccination Companies in Global Market, by Revenue in 2023
3.5 Global Companies Vaccines & Vaccination Product Type
3.6 Tier 1, Tier 2 and Tier 3 Vaccines & Vaccination Players in Global Market
3.6.1 List of Global Tier 1 Vaccines & Vaccination Companies
3.6.2 List of Global Tier 2 and Tier 3 Vaccines & Vaccination Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Vaccines & Vaccination Market Size Markets, 2023 & 2030
4.1.2 Subunit vaccines
4.1.3 Live attenuated vaccines
4.1.4 Conjugate vaccines
4.1.5 Inactivated vaccines
4.1.6 Recombinant vector vaccines
4.1.7 Toxoid vaccines
4.1.8 Synthetic vaccines
4.1.9 Dendritic cell vaccines
4.2 By Type - Global Vaccines & Vaccination Revenue & Forecasts
4.2.1 By Type - Global Vaccines & Vaccination Revenue, 2019-2024
4.2.2 By Type - Global Vaccines & Vaccination Revenue, 2025-2030
4.2.3 By Type - Global Vaccines & Vaccination Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Vaccines & Vaccination Market Size, 2023 & 2030
5.1.2 Baby Vaccine
5.1.3 Adult Special Vaccine
5.1.4 Other
5.2 By Application - Global Vaccines & Vaccination Revenue & Forecasts
5.2.1 By Application - Global Vaccines & Vaccination Revenue, 2019-2024
5.2.2 By Application - Global Vaccines & Vaccination Revenue, 2025-2030
5.2.3 By Application - Global Vaccines & Vaccination Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Vaccines & Vaccination Market Size, 2023 & 2030
6.2 By Region - Global Vaccines & Vaccination Revenue & Forecasts
6.2.1 By Region - Global Vaccines & Vaccination Revenue, 2019-2024
6.2.2 By Region - Global Vaccines & Vaccination Revenue, 2025-2030
6.2.3 By Region - Global Vaccines & Vaccination Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Vaccines & Vaccination Revenue, 2019-2030
6.3.2 US Vaccines & Vaccination Market Size, 2019-2030
6.3.3 Canada Vaccines & Vaccination Market Size, 2019-2030
6.3.4 Mexico Vaccines & Vaccination Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Vaccines & Vaccination Revenue, 2019-2030
6.4.2 Germany Vaccines & Vaccination Market Size, 2019-2030
6.4.3 France Vaccines & Vaccination Market Size, 2019-2030
6.4.4 U.K. Vaccines & Vaccination Market Size, 2019-2030
6.4.5 Italy Vaccines & Vaccination Market Size, 2019-2030
6.4.6 Russia Vaccines & Vaccination Market Size, 2019-2030
6.4.7 Nordic Countries Vaccines & Vaccination Market Size, 2019-2030
6.4.8 Benelux Vaccines & Vaccination Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Vaccines & Vaccination Revenue, 2019-2030
6.5.2 China Vaccines & Vaccination Market Size, 2019-2030
6.5.3 Japan Vaccines & Vaccination Market Size, 2019-2030
6.5.4 South Korea Vaccines & Vaccination Market Size, 2019-2030
6.5.5 Southeast Asia Vaccines & Vaccination Market Size, 2019-2030
6.5.6 India Vaccines & Vaccination Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Vaccines & Vaccination Revenue, 2019-2030
6.6.2 Brazil Vaccines & Vaccination Market Size, 2019-2030
6.6.3 Argentina Vaccines & Vaccination Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Vaccines & Vaccination Revenue, 2019-2030
6.7.2 Turkey Vaccines & Vaccination Market Size, 2019-2030
6.7.3 Israel Vaccines & Vaccination Market Size, 2019-2030
6.7.4 Saudi Arabia Vaccines & Vaccination Market Size, 2019-2030
6.7.5 UAE Vaccines & Vaccination Market Size, 2019-2030
7 Vaccines & Vaccination Companies Profiles
7.1 Abbott
7.1.1 Abbott Company Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Vaccines & Vaccination Major Product Offerings
7.1.4 Abbott Vaccines & Vaccination Revenue in Global Market (2019-2024)
7.1.5 Abbott Key News & Latest Developments
7.2 AstraZeneca
7.2.1 AstraZeneca Company Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Vaccines & Vaccination Major Product Offerings
7.2.4 AstraZeneca Vaccines & Vaccination Revenue in Global Market (2019-2024)
7.2.5 AstraZeneca Key News & Latest Developments
7.3 Bavarian Nordic
7.3.1 Bavarian Nordic Company Summary
7.3.2 Bavarian Nordic Business Overview
7.3.3 Bavarian Nordic Vaccines & Vaccination Major Product Offerings
7.3.4 Bavarian Nordic Vaccines & Vaccination Revenue in Global Market (2019-2024)
7.3.5 Bavarian Nordic Key News & Latest Developments
7.4 Novartis
7.4.1 Novartis Company Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Vaccines & Vaccination Major Product Offerings
7.4.4 Novartis Vaccines & Vaccination Revenue in Global Market (2019-2024)
7.4.5 Novartis Key News & Latest Developments
7.5 Bharat Biotech
7.5.1 Bharat Biotech Company Summary
7.5.2 Bharat Biotech Business Overview
7.5.3 Bharat Biotech Vaccines & Vaccination Major Product Offerings
7.5.4 Bharat Biotech Vaccines & Vaccination Revenue in Global Market (2019-2024)
7.5.5 Bharat Biotech Key News & Latest Developments
7.6 Bio-Med
7.6.1 Bio-Med Company Summary
7.6.2 Bio-Med Business Overview
7.6.3 Bio-Med Vaccines & Vaccination Major Product Offerings
7.6.4 Bio-Med Vaccines & Vaccination Revenue in Global Market (2019-2024)
7.6.5 Bio-Med Key News & Latest Developments
7.7 CSL
7.7.1 CSL Company Summary
7.7.2 CSL Business Overview
7.7.3 CSL Vaccines & Vaccination Major Product Offerings
7.7.4 CSL Vaccines & Vaccination Revenue in Global Market (2019-2024)
7.7.5 CSL Key News & Latest Developments
7.8 Emergent BioSolutions
7.8.1 Emergent BioSolutions Company Summary
7.8.2 Emergent BioSolutions Business Overview
7.8.3 Emergent BioSolutions Vaccines & Vaccination Major Product Offerings
7.8.4 Emergent BioSolutions Vaccines & Vaccination Revenue in Global Market (2019-2024)
7.8.5 Emergent BioSolutions Key News & Latest Developments
7.9 GSK
7.9.1 GSK Company Summary
7.9.2 GSK Business Overview
7.9.3 GSK Vaccines & Vaccination Major Product Offerings
7.9.4 GSK Vaccines & Vaccination Revenue in Global Market (2019-2024)
7.9.5 GSK Key News & Latest Developments
7.10 Johnson & Johnson
7.10.1 Johnson & Johnson Company Summary
7.10.2 Johnson & Johnson Business Overview
7.10.3 Johnson & Johnson Vaccines & Vaccination Major Product Offerings
7.10.4 Johnson & Johnson Vaccines & Vaccination Revenue in Global Market (2019-2024)
7.10.5 Johnson & Johnson Key News & Latest Developments
7.11 Pfizer
7.11.1 Pfizer Company Summary
7.11.2 Pfizer Business Overview
7.11.3 Pfizer Vaccines & Vaccination Major Product Offerings
7.11.4 Pfizer Vaccines & Vaccination Revenue in Global Market (2019-2024)
7.11.5 Pfizer Key News & Latest Developments
7.12 Merck
7.12.1 Merck Company Summary
7.12.2 Merck Business Overview
7.12.3 Merck Vaccines & Vaccination Major Product Offerings
7.12.4 Merck Vaccines & Vaccination Revenue in Global Market (2019-2024)
7.12.5 Merck Key News & Latest Developments
7.13 Sanofi
7.13.1 Sanofi Company Summary
7.13.2 Sanofi Business Overview
7.13.3 Sanofi Vaccines & Vaccination Major Product Offerings
7.13.4 Sanofi Vaccines & Vaccination Revenue in Global Market (2019-2024)
7.13.5 Sanofi Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Vaccines & Vaccination Market Opportunities & Trends in Global Market
Table 2. Vaccines & Vaccination Market Drivers in Global Market
Table 3. Vaccines & Vaccination Market Restraints in Global Market
Table 4. Key Players of Vaccines & Vaccination in Global Market
Table 5. Top Vaccines & Vaccination Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Vaccines & Vaccination Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Vaccines & Vaccination Revenue Share by Companies, 2019-2024
Table 8. Global Companies Vaccines & Vaccination Product Type
Table 9. List of Global Tier 1 Vaccines & Vaccination Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Vaccines & Vaccination Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Vaccines & Vaccination Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Vaccines & Vaccination Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Vaccines & Vaccination Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Vaccines & Vaccination Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Vaccines & Vaccination Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Vaccines & Vaccination Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Vaccines & Vaccination Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Vaccines & Vaccination Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Vaccines & Vaccination Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Vaccines & Vaccination Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Vaccines & Vaccination Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Vaccines & Vaccination Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Vaccines & Vaccination Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Vaccines & Vaccination Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Vaccines & Vaccination Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Vaccines & Vaccination Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Vaccines & Vaccination Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Vaccines & Vaccination Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Vaccines & Vaccination Revenue, (US$, Mn), 2025-2030
Table 30. Abbott Company Summary
Table 31. Abbott Vaccines & Vaccination Product Offerings
Table 32. Abbott Vaccines & Vaccination Revenue (US$, Mn) & (2019-2024)
Table 33. Abbott Key News & Latest Developments
Table 34. AstraZeneca Company Summary
Table 35. AstraZeneca Vaccines & Vaccination Product Offerings
Table 36. AstraZeneca Vaccines & Vaccination Revenue (US$, Mn) & (2019-2024)
Table 37. AstraZeneca Key News & Latest Developments
Table 38. Bavarian Nordic Company Summary
Table 39. Bavarian Nordic Vaccines & Vaccination Product Offerings
Table 40. Bavarian Nordic Vaccines & Vaccination Revenue (US$, Mn) & (2019-2024)
Table 41. Bavarian Nordic Key News & Latest Developments
Table 42. Novartis Company Summary
Table 43. Novartis Vaccines & Vaccination Product Offerings
Table 44. Novartis Vaccines & Vaccination Revenue (US$, Mn) & (2019-2024)
Table 45. Novartis Key News & Latest Developments
Table 46. Bharat Biotech Company Summary
Table 47. Bharat Biotech Vaccines & Vaccination Product Offerings
Table 48. Bharat Biotech Vaccines & Vaccination Revenue (US$, Mn) & (2019-2024)
Table 49. Bharat Biotech Key News & Latest Developments
Table 50. Bio-Med Company Summary
Table 51. Bio-Med Vaccines & Vaccination Product Offerings
Table 52. Bio-Med Vaccines & Vaccination Revenue (US$, Mn) & (2019-2024)
Table 53. Bio-Med Key News & Latest Developments
Table 54. CSL Company Summary
Table 55. CSL Vaccines & Vaccination Product Offerings
Table 56. CSL Vaccines & Vaccination Revenue (US$, Mn) & (2019-2024)
Table 57. CSL Key News & Latest Developments
Table 58. Emergent BioSolutions Company Summary
Table 59. Emergent BioSolutions Vaccines & Vaccination Product Offerings
Table 60. Emergent BioSolutions Vaccines & Vaccination Revenue (US$, Mn) & (2019-2024)
Table 61. Emergent BioSolutions Key News & Latest Developments
Table 62. GSK Company Summary
Table 63. GSK Vaccines & Vaccination Product Offerings
Table 64. GSK Vaccines & Vaccination Revenue (US$, Mn) & (2019-2024)
Table 65. GSK Key News & Latest Developments
Table 66. Johnson & Johnson Company Summary
Table 67. Johnson & Johnson Vaccines & Vaccination Product Offerings
Table 68. Johnson & Johnson Vaccines & Vaccination Revenue (US$, Mn) & (2019-2024)
Table 69. Johnson & Johnson Key News & Latest Developments
Table 70. Pfizer Company Summary
Table 71. Pfizer Vaccines & Vaccination Product Offerings
Table 72. Pfizer Vaccines & Vaccination Revenue (US$, Mn) & (2019-2024)
Table 73. Pfizer Key News & Latest Developments
Table 74. Merck Company Summary
Table 75. Merck Vaccines & Vaccination Product Offerings
Table 76. Merck Vaccines & Vaccination Revenue (US$, Mn) & (2019-2024)
Table 77. Merck Key News & Latest Developments
Table 78. Sanofi Company Summary
Table 79. Sanofi Vaccines & Vaccination Product Offerings
Table 80. Sanofi Vaccines & Vaccination Revenue (US$, Mn) & (2019-2024)
Table 81. Sanofi Key News & Latest Developments
List of Figures
Figure 1. Vaccines & Vaccination Segment by Type in 2023
Figure 2. Vaccines & Vaccination Segment by Application in 2023
Figure 3. Global Vaccines & Vaccination Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Vaccines & Vaccination Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Vaccines & Vaccination Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Vaccines & Vaccination Revenue in 2023
Figure 8. By Type - Global Vaccines & Vaccination Revenue Market Share, 2019-2030
Figure 9. By Application - Global Vaccines & Vaccination Revenue Market Share, 2019-2030
Figure 10. By Type - Global Vaccines & Vaccination Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Vaccines & Vaccination Revenue Market Share, 2019-2030
Figure 12. By Application - Global Vaccines & Vaccination Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Vaccines & Vaccination Revenue Market Share, 2019-2030
Figure 14. By Region - Global Vaccines & Vaccination Revenue Market Share, 2019-2030
Figure 15. By Country - North America Vaccines & Vaccination Revenue Market Share, 2019-2030
Figure 16. US Vaccines & Vaccination Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Vaccines & Vaccination Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Vaccines & Vaccination Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Vaccines & Vaccination Revenue Market Share, 2019-2030
Figure 20. Germany Vaccines & Vaccination Revenue, (US$, Mn), 2019-2030
Figure 21. France Vaccines & Vaccination Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Vaccines & Vaccination Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Vaccines & Vaccination Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Vaccines & Vaccination Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Vaccines & Vaccination Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Vaccines & Vaccination Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Vaccines & Vaccination Revenue Market Share, 2019-2030
Figure 28. China Vaccines & Vaccination Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Vaccines & Vaccination Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Vaccines & Vaccination Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Vaccines & Vaccination Revenue, (US$, Mn), 2019-2030
Figure 32. India Vaccines & Vaccination Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Vaccines & Vaccination Revenue Market Share, 2019-2030
Figure 34. Brazil Vaccines & Vaccination Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Vaccines & Vaccination Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Vaccines & Vaccination Revenue Market Share, 2019-2030
Figure 37. Turkey Vaccines & Vaccination Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Vaccines & Vaccination Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Vaccines & Vaccination Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Vaccines & Vaccination Revenue, (US$, Mn), 2019-2030
Figure 41. Abbott Vaccines & Vaccination Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. AstraZeneca Vaccines & Vaccination Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Bavarian Nordic Vaccines & Vaccination Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Novartis Vaccines & Vaccination Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Bharat Biotech Vaccines & Vaccination Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Bio-Med Vaccines & Vaccination Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. CSL Vaccines & Vaccination Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Emergent BioSolutions Vaccines & Vaccination Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. GSK Vaccines & Vaccination Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Johnson & Johnson Vaccines & Vaccination Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Pfizer Vaccines & Vaccination Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Merck Vaccines & Vaccination Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. Sanofi Vaccines & Vaccination Revenue Year Over Year Growth (US$, Mn) & (2019-2024)

Offer REPORT BUYING OPTIONS

USD GBP EURO YEN Single User Price
USD GBP EURO YEN Multi User Price
USD GBP EURO YEN Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount